For: | Elkady A, Aboulfotuh S, Ali EM, Sayed D, Abdel-Aziz NM, Ali AM, Murakami S, Iijima S, Tanaka Y. Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt. World J Gastroenterol 2013; 19(37): 6214-6220 [PMID: 24115819 DOI: 10.3748/wjg.v19.i37.6214] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i37/6214.htm |
Number | Citing Articles |
1 |
Ghada F. Helaly, Ebtisam F. El Ghazzawi, Sherine M. Shawky, Farag M. Farag. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt. Journal of Infection and Public Health 2015; 8(6): 562 doi: 10.1016/j.jiph.2015.04.019
|
2 |
C. Sagnelli, M. Macera, M. Pisaturo, R. Zampino, M. Coppola, E. Sagnelli. Occult HBV infection in the oncohematological setting. Infection 2016; 44(5): 575 doi: 10.1007/s15010-016-0891-1
|
3 |
Jason T. Blackard, Kenneth E. Sherman. Hepatitis B virus (HBV) reactivation—The potential role of direct‐acting agents for hepatitis C virus (HCV). Reviews in Medical Virology 2018; 28(4) doi: 10.1002/rmv.1984
|
4 |
Mona Fouad, Omar Abdel-Rahman. Combination of transarterial chemoembolisation (TACE) plus antivirals for the management of hepatitis B-related hepatocellular carcinoma: A systematic review of the literature. Arab Journal of Gastroenterology 2015; 16(2): 40 doi: 10.1016/j.ajg.2015.03.003
|
5 |
Mohammed El-Mowafy, Mohamed Elegezy, Mohamed El-Mesery, Abdelaziz Elgaml. Novel method for cloning of hepatitis B virus DNA using the In-Fusion enzyme. Gene Reports 2023; 31: 101765 doi: 10.1016/j.genrep.2023.101765
|
6 |
Ashraf Elbahrawy, Alshimaa Alaboudy, Walid El Moghazy, Ahmed Elwassief, Ahmed Alashker, Abdallah Mahmoud Abdallah. Occult hepatitis B virus infection in Egypt. World Journal of Hepatology 2015; 7(12): 1671-1678 doi: 10.4254/wjh.v7.i12.1671
|
7 |
Abeer Elkady, Sayuki Iijima, Sahar Aboulfotuh, Elsayed Mostafa Ali, Douaa Sayed, Nashwa M Abdel-Aziz, Amany M Ali, Shuko Murakami, Masanori Isogawa, Yasuhito Tanaka. Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt. World Journal of Hepatology 2017; 9(9): 477-486 doi: 10.4254/wjh.v9.i9.477
|
8 |
Michee M Bazie, Mahamoudou Sanou, Florencia Wendkuuni Djigma, Tegwinde Rebeca Compaore, Dorcas Obiri-Yeboah, Benoît Kabamba, Bolni Marius Nagalo, Jacques Simpore, Rasmata Ouédraogo. Genetic diversity and occult hepatitis B infection in Africa: A comprehensive review. World Journal of Hepatology 2024; 16(5): 843-859 doi: 10.4254/wjh.v16.i5.843
|
9 |
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic. Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression. Viruses 2019; 11(9): 778 doi: 10.3390/v11090778
|
10 |
|
11 |
Mohammed El-Mowafy, Mohamed Elegezy, Mohamed El-Mesery, Abdelaziz Elgaml. Characterization of a breakthrough vaccine escape strain associated with overt hepatitis B virus infection. Virus Genes 2024; 60(2): 235 doi: 10.1007/s11262-024-02055-w
|
12 |
Evangelista Sagnelli, Mariantonietta Pisaturo, Salvatore Martini, Pietro Filippini, Caterina Sagnelli, Nicola Coppola. Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World Journal of Hepatology 2014; 6(6): 384-393 doi: 10.4254/wjh.v6.i6.384
|
13 |
Rhiannon M. Bath, Brandelyn E. Doering, Michael D. Nailor, Kellie J. Goodlet. Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients With Prior Functional Cure: A Systematic Review. Annals of Pharmacotherapy 2019; 53(3): 294 doi: 10.1177/1060028018800501
|
14 |
Tamer A. Elbedewy, Hossam Eldin A. Elashtokhy, Enaam S. Rabee, Gamal E. Kheder. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: Significance of hepatitis B core antibodies screening. Journal of the Egyptian National Cancer Institute 2015; 27(1): 11 doi: 10.1016/j.jnci.2015.01.004
|
15 |
Elio Castagnola, Eliana Ruberto, Alfredo Guarino. Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000. World Journal of Gastroenterology 2016; 22(25): 5853-5866 doi: 10.3748/wjg.v22.i25.5853
|
16 |
Nivin Abdel-azim, Lamiaa Fadel Alkilany, Zeinab Korany Hassan, Noha Gaber. Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients. Infection 2023; 51(1): 203 doi: 10.1007/s15010-022-01878-9
|
17 |
Kazuhiko Hayashi, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Yoshihiko Tachi, Tetsuya Ishikawa, Yoshiaki Katano, Kentaro Yoshioka, Hidenori Toyoda, Takashi Kumada, Hidemi Goto, Yoshiki Hirooka. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy. Journal of Gastroenterology 2016; 51(11): 1081 doi: 10.1007/s00535-016-1187-z
|
18 |
Mohammed El‐Mowafy, Abdelaziz Elgaml, Mohamed El‐Mesery, Mohamed Elegezy. Molecular analysis of Hepatitis B virus sub‐genotypes and incidence of preS1/preS2 region mutations in HBV‐infected Egyptian patients from Mansoura. Journal of Medical Virology 2017; 89(9): 1559 doi: 10.1002/jmv.24828
|
19 |
Pengfei Deng, Tian Yang, Hua Zhang, Fen Zhou, Caoyi Xue, Yi Fei, Yijin Gao. Prospective clinical trial of hepatitis B vaccination for children with hematological malignancies: a study on the safety and immunogenicity efficacy. Human Vaccines & Immunotherapeutics 2021; 17(11): 4578 doi: 10.1080/21645515.2021.1953303
|